Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus

Abstract Glycated hemoglobin (HbA1c) is widely accepted as the most reliable measure of long‐term glycemia. However, there is disagreement among professional medical societies on a proper glycemic target for long‐term benefits in type 2 diabetes (T2D). The use of some glucose‐lowering drugs was asso...

Full description

Bibliographic Details
Main Authors: Masayuki Ikeda, Rumiko Shimazawa
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Journal of General and Family Medicine
Subjects:
Online Access:https://doi.org/10.1002/jgf2.244

Similar Items